[Clinical observations on the action of the new benzodiazepine, B 5833 (camazepm)].
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D007046:Hysteria / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002219:Carbamates; D014149:Tranquilizing Agents
Osservazioni cliniche sull'attività del nuovo benzodiazepinico, B 5833 (camazepam)